These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 11403226)
1. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment. Gupta M; Noel GJ; Schaefer M; Friedman D; Bussel J; Johann-Liang R J Clin Immunol; 2001 May; 21(3):193-9. PubMed ID: 11403226 [TBL] [Abstract][Full Text] [Related]
2. Do cytokines correlate with refractory Kawasaki disease in children? Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603 [TBL] [Abstract][Full Text] [Related]
3. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease. Guo MM; Tseng WN; Ko CH; Pan HM; Hsieh KS; Kuo HC Allergy; 2015 Mar; 70(3):310-8. PubMed ID: 25585854 [TBL] [Abstract][Full Text] [Related]
4. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease. Ge X; Li CR; Yang J; Wang GB Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273 [TBL] [Abstract][Full Text] [Related]
5. Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease. Jin J; Wang J; Lu Y; Fan Z; Huang N; Ma L; Yu H Indian J Pediatr; 2019 Mar; 86(3):250-255. PubMed ID: 30159809 [TBL] [Abstract][Full Text] [Related]
6. Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease. Armaroli G; Verweyen E; Pretzer C; Kessel K; Hirono K; Ichida F; Okabe M; Cabral DA; Foell D; Brown KL; Kessel C Arthritis Rheumatol; 2019 May; 71(5):792-804. PubMed ID: 30447136 [TBL] [Abstract][Full Text] [Related]
7. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages. Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease. Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694 [TBL] [Abstract][Full Text] [Related]
9. Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease. Suzuki H; Uemura S; Tone S; Iizuka T; Koike M; Hirayama K; Maeda J Eur J Pediatr; 1996 Apr; 155(4):291-6. PubMed ID: 8777922 [TBL] [Abstract][Full Text] [Related]
10. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease]. Peng Q; Wu Q; Chen CH; Hong H; Zhang LY Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593 [TBL] [Abstract][Full Text] [Related]
11. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition. Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients. Sato S; Kawashima H; Kashiwagi Y; Hoshika A Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640 [TBL] [Abstract][Full Text] [Related]
13. Changes in Peripheral Blood Neutrophils, Lymphocytes and IL-10 in Children with Kawasaki Disease from Different Age Groups Undergoing Intravenous Immunoglobulin: A Retrospective Study. Zhang C; Zhang X; Shen J; Lu X; Zhang J; Chen S Mediators Inflamm; 2020; 2020():5213451. PubMed ID: 33293897 [TBL] [Abstract][Full Text] [Related]
15. [Changes in serum levels of resistin and visfatin in pediatric patients with acute Kawasaki disease following intravenous immune globulin treatment]. Fu SF; Yu DL; Lv DY; Chen FY Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jan; 16(1):44-7. PubMed ID: 24461177 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of neutrophil activation cytokines in Kawasaki disease. Suzuki H; Noda E; Miyawaki M; Takeuchi T; Uemura S; Koike M Pediatr Int; 2001 Apr; 43(2):115-9. PubMed ID: 11285059 [TBL] [Abstract][Full Text] [Related]
18. Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange. Fujimaru T; Ito S; Masuda H; Oana S; Kamei K; Ishiguro A; Kato H; Abe J Cytokine; 2014 Dec; 70(2):156-60. PubMed ID: 25082649 [TBL] [Abstract][Full Text] [Related]
19. Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients. Le Meur Y; Lorgeot V; Aldigier JC; Wijdenes J; Leroux-Robert C; Praloran V Nephrol Dial Transplant; 1999 Oct; 14(10):2420-6. PubMed ID: 10528667 [TBL] [Abstract][Full Text] [Related]
20. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease. Hu P; Jiang GM; Wu Y; Huang BY; Liu SY; Zhang DD; Xu Y; Wu YF; Xia X; Wei W; Hu B Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]